Rivaroxaban

The Safety and Efficacy Of Rivaroxaban and Ticagrelor for Patients With Atrial Fibrillation After Percutaneous Coronary Intervention

Pill-in-the-POCKET Oral Anticoagulation Strategy After AF Catheter Ablation

A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants

THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)

COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation

Efficacy and Safety of Oral Rivaroxaban in Cerebrosinovenous Thrombosis

Comparing the Safety and Efficacy of Apixaban and Rivaroxaban

Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement

Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia

Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in IntraCranial Atherosclerotic diseaSe (CATIS- ICAS)

High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in France

Anticoagulation in Patients With Venous Thromboembolism and Cancer

Complications and Antiplatelet and Anticoagulant Therapy in Vascular Surgery.

Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

Thromboprophylaxis in Lower Limb Immobilisation

Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies

A Study to Learn About the Effects of Medicines That Help in Thinning the Blood in People With Atrial Fibrillation (AF) Between 2016 and 2020 in France

Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical Therapy

Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism

Comparison of Bleeding Risk Between Rivaroxaban and Apixaban: The Pilot Study